<http://schema.org/description>
"A U.S. federal health agency said on Wednesday it had &amp;quot;expressly advised&amp;quot; Mylan NV (MYL.O) that the drugmaker had improperly classified its EpiPen emergency allergy treatment in a way that allowed it to pay lower rebates to state health programs."^^<http://www.w3.org/2001/XMLSchema#string>
<http://in.reuters.com/article/us-congress-mylan-nl-idINKCN11Y1X5>